Xiaohu Xu

Dr. Xiaohu Xu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Phytomedicine
Verified
Journal Article
Open access
ZWZhi Wang
Zhi Wang
KNKexin Nie
Kexin Nie
HSHao Su
Hao Su
YTYueheng Tang
Yueheng Tang
HWHongzhan Wang
Hongzhan Wang
HDHui Dong
Hui Dong
Polycystic ovary syndrome (PCOS) is a clinical syndrome with reproductive and endocrine disorders. Berberine is a monomer from Chinese herbs such as Coptis chinensis, whose effect on improving ovulation and endometrial receptivity of PCOS is uncertain. To evaluate the effect of berberine on improving PCOS and explore the mechanism. The rat model of PCOS was induced by intraperitoneal injection of testosterone propionate. Then they was divided into model (Mod) group, low-dose of berberine (BL) group, high-dose of berberine (BH) group and metformin (Met) group as well as a control (Con) group was established. Ovary morphology, hormone level, glucolipid metabolism were measured. UID-mRNA-seq of ovary tissue was conducted to seek the mechanism of berberine on improving ovulation. Three biomarkers of endometrial receptivity were also examined in endometrium by immunohistochemistry. The number of cystic follicles was increased while the number of corpus luteum was decreased in the rats of Mod group. These changes could be reversed by high-dose of berberine intervention. Berberine could also decrease the levels of serum luteinizing hormone (LH) and total cholesterol (TC) in PCOS rats. Meanwhile, berberine improved the impairment of abnormal oral glucose tolerance without affecting fasting insulin level and Homeostasis model assessment-insulin resistance (HOMA-IR). Luteinizing hormone/ choriogonadotropin receptor (LHCGR) and cytochrome P450 Family 19 Subfamily A Member 1 (CYP19A1) were focused via RNA-seq of ovary. Protein expression in ovary and mRNA expression in granulosa cell of LHCGR and CYP19A1 were decreased in Mod group and rescued by the intervention of berberine. A decrease of endometrial thickness and an increase of integrin αvβ3 and lysophosphatidic acid receptor 3 (LPAR3) protein expression were observed in Mod group, which could be also reversed by berberbine. Berberine could improve ovulation in PCOS and the mechanism might be associated with up-regulating LHCGR and CYP19A1. Berberine could also improve endometrial receptivity through down-regualting αvβ3 and LPAR3.

26 April 2020 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
XXXiaohu Xu
Xiaohu Xu
MZMing-Min Zhang
Ming-Min Zhang
XWXiao Wu
Xiao Wu
SXSha-Bei Xu
Sha-Bei Xu
WWWei Wang
Wei Wang
GHGuang-Ying Huang
Guang-Ying Huang

31 January 2017 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
XWXiao Wu
Xiao Wu
CZCuihong Zheng
Cuihong Zheng
XXXiaohu Xu
Xiaohu Xu
PDPei Ding
Pei Ding
FXFan Xiong
Fan Xiong
GHGuangying Huang
Guangying Huang
Background and Aim. To investigate the efficacy and safety of electroacupuncture (EA) with different current intensities for functional constipation (FC) and to assess whether the effects of EA with different current intensities are superior to the mosapride. Methods. Patients with FC were randomly divided into low current intensity group (LCI), high current intensity group (HCI), and mosapride group (MC). The primary outcome was three or more spontaneous bowel movements (SBMs) per week and an increase of one or more SBMs from baseline during at least 3 of the 4 weeks. Results. The primary outcome was reached by 53.45%, 66.15%, and 52.24% of the patients who received LCI, HCI, and mosapride, respectively. EA can significantly improve the weekly SBMs and stool consistency and reduce straining severity (p < 0.0001, all). HCI improved the quality of life better than mosapride (p < 0.05) and reduced the proportion of severe constipation more than LCI and mosapride (p < 0.05, both). Conclusions. EA is effective and safe at both current intensities for FC; therapeutic effects of LCI and HCI are not superior to mosapride. EA is superior to mosapride in improving patients’ life quality and satisfaction level of treatment; EA has fewer adverse events than mosapride.

29 October 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
XXXiaohu Xu
Xiaohu Xu
CZCuiHong Zheng
CuiHong Zheng
MZMingmin Zhang
Mingmin Zhang
WWWei Wang
Wei Wang
GHGuangYing Huang
GuangYing Huang
Functional constipation (FC) is a common gastrointestinal disorder (FGIDs) which has a major impact on the quality of life. Acupuncture is widely used as an alternative and complementary medicine (CAM) for FC, but the available evidence of its effectiveness is scarce. Therefore, we will perform a randomized controlled trial to determine whether acupuncture improves symptom and quality of life in FC patients more effectively than sham acupuncture or gastrointestinal prokinetic agent. This article will report the protocol of the trial.

1 June 2020 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
XXXiaohu Xu
Xiaohu Xu
QHQian Hu
Qian Hu
LZLi-Shan Zhou
Li-Shan Zhou
LXLi-Jun Xu
Li-Jun Xu
XZXin Zou
Xin Zou
PYPing Yi
Ping Yi

1 January 2013 in Trials
Verified
Journal Article
Open access
PDF file
CZCui H Zheng
Cui H Zheng
GHGuang Y Huang
Guang Y Huang
XXXiaohu Xu
Xiaohu Xu
YWYing Wang
Ying Wang
MZMing M Zhang
Ming M Zhang
BZBing Zhu
Bing Zhu
Functional constipation (FC) is highly prevalent in the general population of the world and has a substantial negative impact on the health-related quality of life of individuals. Many clinical trials have indicated that acupuncture is effective in the treatment of FC. However, the sample sizes of these previous studies were too small. Furthermore, there are no reports investigating the relationship between the stimulation parameter and the therapeutic effect. We therefore designed a multicenter randomized controlled trial to address these problems and hopefully provide a more conclusive answer to these questions.